Psychiatry and Neurology, Neurology · Cumming, GA
NPI
1902885494
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1400 Northside Forsyth Dr Ste 250
Cumming, GA, 30041
Phone (770) 889-7118
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
780 services
Medicare patients, 2024
475
Average age 74
Drug cost, 2024
$2.0M
5,018 prescriptions
Company payments, 2025
$1,238
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Reginald V Hall was code 99213 (office e&m - established), 364 times for 277 patients. In total Reginald V Hall billed 780 services in 15 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 364 | 277 | $66.36 | $24K |
| 99204 Office E&M - New | Office | 137 | 137 | $121.27 | $17K |
| 99214 Office E&M - Established | Office | 78 | 73 | $97.53 | $7,607 |
| 99222 Hospital E&M - Initial | Facility | 64 | 61 | $98.86 | $6,327 |
| 99231 Hospital E&M - Subsequent | Facility | 45 | 36 | $36.42 | $1,639 |
| 95816 Neurologic | Facility | 42 | 42 | $42.97 | $1,805 |
| 99232 Hospital E&M - Subsequent | Facility | 40 | 33 | $60.20 | $2,408 |
By year: 2022 $66K for 826 services; 2023 $61K for 788 services; 2024 $62K for 780 services.
Medicare prescription drug claims, 2024
In 2024, the drug Reginald V Hall prescribed most often to Medicare patients was Memantine Hcl Er (Memantine Hcl), with 594 prescriptions and refills. In total Reginald V Hall wrote 5,018 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Er Memantine Hcl | 594 | 1,136 | 164 | $58K |
| Gabapentin Generic | 400 | 847 | 126 | $6,813 |
| Donepezil Hcl Generic | 317 | 777 | 120 | $3,561 |
| Levetiracetam Generic | 253 | 543 | 68 | $7,241 |
| Memantine Hcl Generic | 241 | 512 | 96 | $6,912 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 210 | 357 | 55 | $9,369 |
| Pregabalin Generic | 180 | 253 | 49 | $5,214 |
| Duloxetine Hcl Generic | 149 | 318 | 50 | $2,919 |
| Qulipta Atogepant | 141 | 145 | 17 | $154K |
| Clopidogrel Clopidogrel Bisulfate | 132 | 338 | 46 | $1,447 |
| Topiramate Generic | 128 | 235 | 40 | $1,313 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 116 | 238 | 34 | $1,739 |
| Primidone Generic | 108 | 189 | 28 | $2,780 |
| Ubrelvy Ubrogepant | 101 | 101 | 16 | $155K |
| Quetiapine Fumarate Generic | 91 | 187 | 29 | $1,717 |
Brand drugs: 619 claims; generic drugs: 4,379 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Reginald V Hall $1,238 ($1,238 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $297.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $297 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $280 |
| UCB, Inc. UCB.BR | 7 | $158 |
| ANI Pharmaceuticals, Inc. ANIP | 5 | $107 |
| Janssen Biotech, Inc. JNJ | 3 | $77.85 |
| Pfizer Inc. PFE | 4 | $62.51 |
| Grifols USA, LLC | 2 | $58.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $41 |
| MDD US Operations, LLC | 2 | $38.69 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $26.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.